Results 11 to 20 of about 93,845 (280)

Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs [PDF]

open access: yesMolecules, 2022
The ongoing development of more and more new psychoactive substances continues to be a huge problem in 2022 affecting the European and international drug market. Through slight alterations in the structure of illicit drugs, a way to circumvent the law is
Elisabeth Seibert   +3 more
doaj   +2 more sources

Emergency Physicians' Knowledge of Cannabinoid Designer Drugs [PDF]

open access: yesWestern Journal of Emergency Medicine, 2013
Introduction: The use of synthetic drugs of abuse in the United States has grown in the last few years, with little information available on how much physicians know about these drugs and how they are treating patients using them.
Patrick M Lank   +2 more
doaj   +2 more sources

Designer drugs [PDF]

open access: yesLaboratory Medicine, 2023
Pesce, Amadeo J, Krock, Kevin
openaire   +3 more sources

Stimulation of the Epithelial Na+ Channel in Renal Principal Cells by Gs-Coupled Designer Receptors Exclusively Activated by Designer Drugs [PDF]

open access: yesFrontiers in Physiology, 2021
The activity of the Epithelial Na+ Channel (ENaC) in renal principal cells (PC) fine-tunes sodium excretion and consequently, affects blood pressure.
Antonio G. Soares   +7 more
doaj   +2 more sources

Beyond THC: the new generation of cannabinoid designer drugs [PDF]

open access: yesFrontiers in Behavioral Neuroscience, 2011
Synthetic cannabinoids are functionally similar to delta9-tetrahydrocannabinol (THC), the psychoactive principle of cannabis, and bind to the same cannabinoid receptors in the brain and peripheral organs.
Liana eFattore   +3 more
doaj   +2 more sources

„Dopalacze” – nieprzewidywalne narkotyki. Problem społeczno-prawny

open access: yesFilozofia Publiczna i Edukacja Demokratyczna, 2019
The aim of this article is to present the problem of new psy­choactive substances – designer drugs. New drugs are undoubt­edly a social and legal problem.
Sebastian Matyjek
doaj   +1 more source

Harnessing Deep Convolutional Neural Networks Detecting Synthetic Cannabinoids: A Hybrid Learning Strategy for Handling Class Imbalances in Limited Datasets

open access: yesInventions, 2023
The aim of this research was to develop and deploy efficient deep convolutional neural network (DCNN) frameworks for detecting and discriminating between various categories of designer drugs. These are of particular relevance in forensic contexts, aiding
Catalina Mercedes Burlacu   +3 more
doaj   +1 more source

Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible. [PDF]

open access: yes, 2018
To uncover the circuit-level alterations that underlie atypical sensory processing associated with autism, we adopted a symptom-to-circuit approach in the Fmr1-knockout (Fmr1-/-) mouse model of Fragile X syndrome.
A Contractor   +53 more
core   +2 more sources

Uzasadnienie i propozycja projektu przepisów karnych mających na celu zwalczanie obrotu tak zwanymi dopalaczami przez jednostki samorządu terytorialnego

open access: yesActa Iuris Stetinensis, 2018
In view of the very serious social problem of designer drugs, which is growing with every passing day, we must take resolute and effective action as quickly as possible.
Piotr Jóźwiak
doaj   +1 more source

Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine. [PDF]

open access: yesFarmacja Polska, 2020
Research on using drugs in medicine was almost completely stopped and delegalized in 1971, by Convention on Psychotropic Substances. Most of studies carried out before 1971 were methodologically inappropriate according to current research methodologies ...
Agata Tadeja
doaj   +1 more source

Home - About - Disclaimer - Privacy